Key facts
- Prescribe FIT’s last known valuation is $8.0M (Jun 2024).
- It has raised $15.0M across 6 recorded rounds; the latest was Seed Round ($1.0M) in Oct 2025.
- Notable investors include JobsOhio Ventures, Adolph Lombardi, Annie Upper, Brett Kaufman, David Dickerson — 13 tracked in total.
- Prescribe FIT has filed 7 Form Ds with the SEC since 2021, most recently Apr 2025 ($300K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Prescribe FIT
Funding rounds
6 roundsAbout Prescribe FIT
Developer of a health management application designed to transform lifestyles for optimal health and enhanced wellness. The company's application virtually connects patients and physicians to improve chronic conditions through simple changes to nutrition, physical activity, and lifestyle and delivers end-to-end technologies including remote patient monitoring and on-demand coaches to provide comprehensive and consistent care, enabling healthcare providers to get access to real-time biometric, health and lifestyle data of patients in a simplified way to use in care for chronic conditions.
- Sector
- Healthcare
- HQ
- Columbus, OH, United States
- Founded
- 2017
- Employees
- 79
- Website
- prescribefit.com/
- Ownership
- Privately Held (backing)
Prescribe FIT doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prescribe FIT shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prescribe FIT in its N-PORT filings yet. We sweep new filings monthly.